2 news items
Corvus Pharmaceuticals Announces Pricing Of $30.6M Registered Direct Offering
CRVS
2 May 24
to the satisfaction of customary closing conditions. Since the offering of the Securities was made without an underwriter or a placement agent
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
CRVS
2 May 24
to the satisfaction of customary closing conditions. Since the offering of the Securities was made without an underwriter or a placement agent
- Prev
- 1
- Next